Open an account

BNB Plus

BNBX · NASDAQ

$0.105+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.105

About BNBX

BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 26 full-time employees. The company went IPO on 2001-08-24. Its segments include digital asset treasury, therapeutic deoxyribonucleic acid (DNA) production services, DNA tagging and security products and services. Its digital asset treasury segment is engaged in managing digital assets. Its therapeutic DNA production services segment is engaged in nucleic-acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP and LineaIVT. Its DNA tagging and security products and services segment is engaged in the manufacture and detection of DNA for industrial supply chains and security services. Its subsidiary LineaRx, Inc., is engaged in commercializing nucleic acid production solutions for the biopharmaceutical and diagnostics markets.

Employees
26
Headquarters
Stony Brook, New York
Listed
Aug 24, 2001
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
bnbx.io

BNBX key statistics

Market cap
650.71K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
23.29K
Volume
578
Open price
$0.105
High today
$0.105
Low today
$0.105
52 Week high
$6.17
52 Week low
$0.066

BNB Plus (BNBX) at a glance

As of Oct 20, 2026, BNB Plus (BNBX) shares are priced at $0.105, giving the company a market cap of 650.71K and a price-to-earnings ratio of 0.00.

Volume so far is 578 shares, below the average of 23.29K shares a day.

Over the past year BNB Plus has ranged from $0.066 to $6.17, and now sits 1% of the way up that range.

BNB Plus met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q3 FY25 it reported -$34.00 per share against an estimate of -$38.25.

BNBX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 65.5% on average.

  1. Q4 FY23: reported -$3,900.00 per share against an estimate of -$4,131.00
  2. Q1 FY24: reported -$1,350.00 per share against an estimate of -$4,743.00
  3. Q2 FY24: reported -$3,982.50 per share against an estimate of -$3,442.50
  4. Q3 FY24: reported $352.50 per share against an estimate of -$267.75
  5. Q4 FY24: reported -$240.00 per share against an estimate of -$260.10
  6. Q1 FY25: reported -$420.00 per share against an estimate of -$248.63
  7. Q2 FY25: reported -$230.25 per share against an estimate of -$45.90
  8. Q3 FY25: reported -$34.00 per share against an estimate of -$38.25

BNBX news

  • Press releaseBusiness Wire

    BNB Plus Corp. Announces Strategic Shift to Institutional Technology Infrastructure for Blockchain and AI; Outlines Plan to Monetize Assets

  • Press releaseBusiness Wire

    BNB Plus Corp. Appoints Three New Directors Identified Through Ongoing Strategic Review

  • Press releaseBusiness Wire

    BNB Plus Corp. (BNBX) Announces Transition to Fully Internalized Digital Asset Treasury Management

  • Avi Kapoor

    Crude Oil Surges Over 5%; Twin Vee Powercats Shares Jump

  • Avi Kapoor

    US Stocks Mixed; Dow Gains Over 100 Points

  • Press releaseBusiness Wire

    BNB Plus Corp. (BNBX) Announces Nasdaq Delisting Determination and Transition to OTCQB Market; Company to Seek Review by Nasdaq Listing and Hearing Review Council

  • Press releaseBusiness Wire

    BNB Plus Corp. (BNBX) Secures Initial Commitments for $4.1M in Strategic Financing

  • Caroline Ryan

    Deal Dispatch: QXO Nabs TopBuild For $17 Million, Voya Financial Urged To Evaluate Strategic Options, Pat McGrath Exits Chapter 11

Similar companies

Companies in the same industry as BNB Plus

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.